. XRD pattern of LiGa 5 O 8 :Cr 3+ nanoparticles. The material is identified as cubic LiGa 5 O 8 Figure S2 . NIR images for persistent luminescence and photostimulated persistent luminescence (PSPL) in LGO:Cr nanoparticles. 250 mg LGO:Cr nanoparticles were pressed into a sample holder with diameter of 20 mm. Before imaging, the sample was irradiated by a 254 nm UV lamp for 15 min. (AC) Natural decay of persistent luminescence to 96 h. (DF) Starting from the 96 h time point, the sample was stimulated daily by a white LED flashlight (Olight SR51) for 15 s. All the PSPL images were taken at 10 s after the stimulation. Images (D1), (E1), and (F1) were taken at 1 h after the stimulation. The images were taken by a Pentax digital SLR camera which was connected to an ATN PVS-14 Generation III night vision monocular. The imaging parameter is manual/ISO 400/10 s. The imaging experiment was conducted in a dark room. Figure S3 . Persistent luminescence and PSPL properties of LGO:Cr nanoparticles in aqueous colloidal solution. The concentration of LGO:Cr nanoparticles in solution is 1 mg/mL. The solution was irradiated with a 254 nm UV lamp for 5 min. (A) Persistent luminescence emission spectrum recorded at 1 min after the UV irradiation. (B) The grey curve is the persistent luminescence emission spectrum recorded after 5 h decay. The 5-h decay solution was then stimulated with a white LED flashlight for 10 s. The brown curve is the resulting PSPL emission spectrum. The profiles of the persistent luminescence and PSPL emission spectra of the LGO:Cr nanoparticles in colloidal solution are almost identical to those of the materials in air (see Figure 1 ). . Viability assay with (A) 4T1 murine breast cancer cells, (B) RAW264.7 murine macrophage cells, and (C) murine embryonic stem cells (ESCs). In preparing the 4T1 cells and RAW264.7 cells assay, the cells (2×10 4 /well) were added to the stock solution of PEI-LGO:Cr nanoparticles with concentrations varying from 0 to 100 μg/mL, and co-incubated in 24-well plate for 24 h in RPMI-1640 medium with 10% fetal bovine serum (FBS). The incubated cells were collected by trypsin treatment, followed by centrifugation and re-suspension in 0.01M PBS (1x, pH7.4). Trypan blue solution (0.4%, w/v) was then added into the suspension and the dead cells were counted under a microscope using a hemacytometer. In preparing the mouse ESCs assay, the cells (0.5×10 4 /well) were cultured in 0.1% gelatin-coated 96-well plates using DMEM (Hyclone) medium supplemented with 10% FBS, 10% KSR (Gibco), 1% non-essential amino acids (NEAA), 4 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 0.1 mM βmercaptoethanol, and 1000 U/mL leukemia inhibitory factor (LIF, ESGRO, Chemicon). The cells were maintained in a humidified cell culture incubator at 37C under 5% CO 2 . After 12 h of incubation, the wells were replenished with fresh medium and treated with various concentrations of PEI-LGO (0−150 μg/mL) for 72 h, followed by addition of WST8 solution for 1 h. The plates were read at 450 nm using an OPTImax microplate reader (Molecular Devices), and the percentage of cell viability was then calculated. For all the three types of cells, the measurement at each PEI-LGO:Cr concentration was repeated 3 times. Figure S5 . The impact of PEI-LGO:Cr nanoparticles on the renewal and differentiation of mouse embryonic stem cells (ESCs). Stock solution of PEI-LGO nanoparticles was first sterilized in an autoclave. Mouse ESCs (0.5×10 4 /well) were cultured in 0.1% gelatin-coated 96-well plates using DMEM (Hyclone) medium supplemented with 10% FBS, 10% KSR (Gibco), 1% non-essential amino acids (NEAA), 4 mM L-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, and 0.1 mM β-mercaptoethanol. The cells were maintained in a humidified cell culture incubator at 37 ºC under 5% CO 2 . After 12 h of incubation, the wells were replenished with fresh medium and treated with various concentrations of PEI-LGO:Cr (0−37.5 μg/mL) for 72 h. The cells were then collected and subjected to RNA isolation (RNeasy min kit, QIAGEN), cDNA synthesis (iScript cDNA synthesis kit, BioRad), and qRT-PCR amplification (iQ SYBR Green Supermix, BioRad) using three specific primers, i.e., Nanog, Nestin and Sox17, to identify different mRNAs. Figure S6 . Thin-section TEM images of PEI-LGO:Cr nanoparticle labeled 4T1 cells from different passages. 4T1 cells (1.0×10 6 cells/mL) were added to PEI-LGO:Cr nanoparticles suspension (100 g/mL) and co-incubated in cell culture flask for 2 days using RPMI-1640 medium (with 10% fetal bovine serum). Part of the cells (1 st generation) were collected for TEM imaging and the rest were continuously cultured in medium till the 3 rd generation. Image in (A), (B) and (C) are the thinsection TEM images of the 1 st , 2 nd and 3 rd generation of 4T1 cells loaded with PEI-LGO:Cr nanoparticles. Scale bars, 2 µm. In preparation of the thin-sections, the three generations of cells were fixed with Karnovsky's EM fixative (2.5% glutaraldehyde and 2% paraformaldehyde in 80 mM phosphate buffer, pH 7.3-7.4) for 12 h at 4 C. Secondary fixation was conducted in 1% osmium tetroxide with 1.5% potassium ferrocyanide in double distilled H 2 O for 1 h at 4 °C. Dehydration was done in ethanol. Pure Epon-Araldite resin was added and infiltrated overnight at room temperature. All resin was removed the next day, and fresh resin was added to the appropriate depth. The sample was polymerized for 18 h. Ultrathin sections of cells were obtained by cutting en face (parallel to the surface on which the cells were grown) using a ultramicrotome, and then stained with uranyl acetate and lead citrate before viewing in the TEM.
It is worth noting that no detectable NIR photoluminescence and NIR persistent luminescence signals were recorded from the culture buffers using our FluoroLog-3 spectrofluorometer, indicating that the release of LGO:Cr nanoparticles from the tagged cells during cell culture was negligible. Figure 5 . In Figure 5 , only images taken at 1 min after the stimulation were shown (the lower row). In the actual experiment, PSPL images were taken at 1, 5, 10, 15 and 30 min after the stimulation at the 6 h time point, and 1, 5 and 10 min after the stimulation at the 72 h and 120 h time points. The quantification was achieved by analyzing signals within the region of interests (ROIs) using vendor provided software Living Image (Version 4.3.1 SP1). Figure S11 . Ex vivo images and biodistribution of NIR persistent luminescence signals among tumor and major mouse organs for cell tracking with PEI-LGO:Cr nanoparticles labeled RAW264.7 cells in subcutaneous 4T1 tumor model. The tumor and organs were collected from the mouse in Figure 6C . (A) Background image of major organs, including liver, kidneys, brain, spleen, lung and heart, and tumor before UV irradiation. (B) Image taken after the organs and tumor were irradiated by a 254 nm UV lamp for 15 min. The signals were attributed to the NIR persistent luminescence from the LGO:Cr nanoparticles. Both images were acquired on an IVIS Lumina II imaging system in the bioluminescence mode with the emission filter set as "open", and with an exposure time of 5 min. (C) Biodistribution of the NIR persistent luminescence signals from the organs and tumor. The fluxes (in photons per second) of luminescence from the organs and tumor before and after the UV excitation was recorded on the IVIS system. The net flux of each organ as well as the tumor was obtained by subtracting the flux obtained before UV excitation from the flux obtained after UV excitation. The net flux of each organ and tumor was then normalized to that of the liver. Figure S13 . Ex vivo images and biodistribution of NIR persistent luminescence signals among tumor and major mouse organs for active tumor targeting with c(RGDyK)-conjugated LGO:Cr nanoparticles in subcutaneous 4T1 tumor model. The tumor and organs were collected from the mouse in Figure 6E . (A) Background image of major organs, including liver, spleen, kidney, heart, lung and brain, and tumor before UV irradiation. (B) Image taken after the organs and tumor were irradiated by a 254 nm UV lamp for 15 min. The signals were attributed to the NIR persistent luminescence from the LGO:Cr nanoparticles. Both images were acquired on an IVIS Lumina II imaging system in the bioluminescence mode with the emission filter set as "open", and with an exposure time of 5 min. (C) Biodistribution of the NIR persistent luminescence signals from the organs and tumor. The fluxes (in photons per second) of luminescence from the organs and tumor before and after the UV excitation was recorded on the IVIS system. The net flux of each organ as well as the tumor was obtained by subtracting the flux obtained before UV excitation from the flux obtained after UV excitation. The net flux of each organ and tumor was then normalized to that of the liver. 
